XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
OVERLAYS
Fund
Benchmark
3Y · NAV total return · GBP
First Trust NYSE® Arca® Biotechnology Index Fund: holdings, performance and fees
1Y return+53.4%
3Y return+73.2%
5Y return+68.6%
Top 10 holdings
| Holding | Weight |
|---|---|
| HALOZYME THERAPEUTICS, INC. | 4.3% |
| NEOGENOMICS INC | 3.9% |
| REPLIGEN CORPORATION | 3.9% |
| CORCEPT THERAPEUTICS INC | 3.8% |
| BEONE MEDICINES LTD. | 3.7% |
| REGENERON PHARMACEUTICALS INC | 3.7% |
| NATERA INC | 3.7% |
| AMGEN INC. | 3.7% |
| ARGENX SE | 3.7% |
| GENMAB A/S | 3.6% |
Top sectors
- Biotechnology/Medical100.0%
Top countries
- International100.0%
Holdings, sector and country weightings and performance as reported by FE fundinfo. Weightings are a percentage of the portfolio and may not sum to 100.
AI FORECAST · 12-MONTH
Powered by Claude
FREE PREVIEW
Sign up free to unlock the full AI analysis →
UP—
PREMIUM
PREMIUM
Positives
Risks
600 adviser votes
Unlock the full forecast →
This is an illustrative, model-generated scenario based on stated assumptions. It is not a prediction, a forecast of actual returns, or investment advice. Outcomes may differ materially. Past performance is not a guide to future returns. Capital is at risk.
PORTFOLIO BREAKDOWN